Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomized controlled trial of rivaroxaban for the prevention of major cardiovascular events in patients with coronary or peripheral artery disease (COMPASS - Cardiovascular OutcoMes for People using Anticoagulation StrategieS)

Next Previous
X
Search
Trial Profile

A randomized controlled trial of rivaroxaban for the prevention of major cardiovascular events in patients with coronary or peripheral artery disease (COMPASS - Cardiovascular OutcoMes for People using Anticoagulation StrategieS)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 10 Jul 2024

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Rivaroxaban (Primary) ; Aspirin; Pantoprazole
  • Indications Cardiovascular disorders; Coronary artery disease; Myocardial infarction; Peripheral arterial disorders; Stroke
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Acronyms COMPASS; COMPASS CABG
  • Sponsors Bayer; Bayer HealthCare

    • Most Recent Events

    • 28 Dec 2023 Results cost-effectiveness of this regimen in patients with either stable coronary artery disease (CAD) or peripheral artery disease , published in the American Journal of Cardiovascular Drugs
    • 13 Jan 2023 Results assessing total events and net clinical benefit of rivaroxaban and aspirin published in the American Heart Journal
    • 22 Aug 2022 Status changed from discontinued to completed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top